Meeting/Workshop
4th TMN mini-symposium : Innovative therapies applied to neurosciences
March 20, 2024
Strasbourg (France)
INTRODUCTION
The development of therapeutic strategies targeting human neurological diseases is a major challenge that is driving major innovations in translational medical research. In this symposium, the speakers will present new therapeutic strategies for retinal and neuromuscular diseases, in particular through the use of stem cells and viruses. The symposium organizers will also welcome the director of the PCBIS platform in Strasbourg, which focuses on the identification of active compounds for therapeutic purposes.
This 4th mini-symposium is organised by the Translational Medicine and Neurogenetics Department of the IGBMC based in Illkirch-Graffenstaden (Strasbourg, France), in collaboration with Inserm, the University of Strasbourg and the CNRS. This symposium is led by Manon BOIVIN (PhD), Marianne LEMEE (PhD candidate), Charlotte Schurk (PhD candidate) and Jacqueline.
PROGRAM
9h00 - 9h45
Dr Deniz Dalkara
Institut de la Vision, Paris, France
Early to late stage gene therapy interventions for inherited retinal degenerations
9h50 - 10h35
Dr Pascal Villa
Plateforme de Chimie Biologique Intégrative de Strasbourg (PCBIS)
Ecole Supérieure de Biotechnologie de Strasbourg (ESBS), France
Title to be confirmed
Coffee break
11h00 - 11h45
Dr Walter Habeler
I-STEM, Paris, France
Use of Human Pluripotent Stem Cells for retinal diseases
11h50 - 12h35
Dr Aurélie Goyenvalle
Université Paris Saclay, UFR Simone Veil, Versailles, France
AAV-mediated exon-skipping approaches for the treatment of Duchenne muscular dystrophy and its brain comorbidities
DATES AND VENUE
20th of March, 2024
IGBMC,
1 rue laurent Fries,
Illkirch-Graffenstaden
Auditorium
PLEASE NOTE THAT...
Registration at